Redmond Asset Management LLC Grows Stake in HCA Healthcare Inc (NYSE:HCA)

Redmond Asset Management LLC boosted its position in shares of HCA Healthcare Inc (NYSE:HCA) by 26.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,672 shares of the company’s stock after purchasing an additional 3,027 shares during the quarter. Redmond Asset Management LLC’s holdings in HCA Healthcare were worth $1,983,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Westside Investment Management Inc. purchased a new position in HCA Healthcare during the 2nd quarter worth $34,000. NEXT Financial Group Inc purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at $43,000. Financial Gravity Wealth Inc. purchased a new position in shares of HCA Healthcare in the 1st quarter valued at $47,000. Valeo Financial Advisors LLC purchased a new position in shares of HCA Healthcare in the 1st quarter valued at $66,000. Finally, Rational Advisors LLC increased its holdings in shares of HCA Healthcare by 5,118.2% in the 1st quarter. Rational Advisors LLC now owns 574 shares of the company’s stock valued at $75,000 after acquiring an additional 563 shares during the period. Institutional investors own 70.23% of the company’s stock.

A number of brokerages have recently issued reports on HCA. Zacks Investment Research downgraded HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price target on the stock. in a report on Monday, May 27th. Jefferies Financial Group set a $158.00 price target on HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, April 17th. Goldman Sachs Group upgraded HCA Healthcare from a “neutral” rating to a “buy” rating and lifted their price target for the company from $147.00 to $160.00 in a report on Wednesday, July 10th. Mizuho set a $153.00 price target on HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, July 31st. Finally, Barclays cut their price target on HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a report on Wednesday, April 17th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and seventeen have assigned a buy rating to the company. HCA Healthcare has an average rating of “Buy” and a consensus price target of $153.35.

In other news, SVP Robert A. Waterman sold 33,786 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the transaction, the senior vice president now directly owns 279,551 shares in the company, valued at approximately $37,733,793.98. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Patricia F. Elcan bought 250 shares of the stock in a transaction dated Tuesday, August 6th. The shares were bought at an average price of $124.10 per share, for a total transaction of $31,025.00. The disclosure for this purchase can be found here. Insiders own 2.70% of the company’s stock.

Shares of HCA Healthcare stock traded up $0.88 during trading on Thursday, reaching $124.15. The company’s stock had a trading volume of 22,847 shares, compared to its average volume of 1,891,027. The stock has a market capitalization of $42.90 billion, a P/E ratio of 12.65, a price-to-earnings-growth ratio of 1.08 and a beta of 0.85. HCA Healthcare Inc has a 1-year low of $110.31 and a 1-year high of $147.42. The company has a 50-day moving average price of $135.43.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $2.21 EPS for the quarter, missing the Zacks’ consensus estimate of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The firm had revenue of $12.60 billion for the quarter, compared to analyst estimates of $12.61 billion. During the same period in the prior year, the firm posted $2.29 EPS. The business’s revenue was up 9.3% compared to the same quarter last year. As a group, equities research analysts predict that HCA Healthcare Inc will post 10.35 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Tuesday, September 3rd will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, August 30th. This represents a $1.60 dividend on an annualized basis and a yield of 1.29%. HCA Healthcare’s dividend payout ratio is currently 16.38%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: Mutual funds are not immune from market timing

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.